Subscribe
p1images-istockphoto-com-money-
p1images / iStockphoto.com
23 April 2018Asia-Pacific

Takeda makes fourth offer to buy Shire

Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion ($61.6 billion).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Lundbeck and Takeda take on Lupin over anti-depressant ANDA
23 May 2018   Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).
Big Pharma
Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition
31 October 2018   Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Lundbeck and Takeda take on Lupin over anti-depressant ANDA
23 May 2018   Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).
Big Pharma
Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition
31 October 2018   Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Lundbeck and Takeda take on Lupin over anti-depressant ANDA
23 May 2018   Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).
Big Pharma
Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition
31 October 2018   Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent